Parker Stuart B. 4
4 · HEALTHEQUITY, INC. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
HealthEquity (HQY) Director Stuart B. Parker Receives 1,263 RSUs
What Happened
- Stuart B. Parker, a director of HealthEquity, Inc. (HQY), was granted 1,263 restricted stock units (RSUs) on February 2, 2026 (transaction code A — award/grant). The filing shows an acquisition price of $0.00 per RSU (no cash paid).
- Vesting: 316 RSUs vested on Feb 2, 2026; 316 RSUs will vest on May 1, 2026 and another 316 on August 1, 2026; the remaining 315 RSUs will vest on November 1, 2026. Vested RSUs will be delivered upon the earlier of a change of control, the reporting person’s termination of service, or death.
Key Details
- Transaction date: 2026-02-02; filing date (Form 4): 2026-02-04 (filed timely).
- Price reported: $0.00 per RSU; total reported acquisition value: $0.
- Shares owned after transaction: not specified in this filing.
- Footnotes: Each RSU represents a contingent right to one share; delivery is subject to the events noted above. A previously filed power of attorney (June 26, 2023) is incorporated by reference.
Context
- RSUs are compensation awards that convert into shares if and when vesting/delivery conditions are met; this is not an open‑market purchase or sale and does not by itself signal the insider buying or selling shares.
- Such grants are routine for directors and executives as part of compensation packages; they should be viewed as compensation actions rather than direct expressions of market sentiment.
Insider Transaction Report
Form 4
Parker Stuart B.
Director
Transactions
- Award
Common Stock
[F1]2026-02-02+1,263→ 23,098 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 316 shares on February 2, 2026. The restricted stock units vest as to 316 shares each on May 1 and August 1 of 2026. The remaining 315 shares will vest on November 1, 2026. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2024 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2024 equity incentive plan), or the reporting person's death.
Signature
/s/ Michael Newton, Attorney-in-Fact|2026-02-04